Article Text

Download PDFPDF
Coeliac disease: between “pizza” and ethics
  1. L Elli
  1. Correspondence to:
    Dr L Elli
    Centre for the Prevention and Diagnosis of Coeliac Disease, IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena-Milan, University of Milan, Via F Sforza 35, 20131, Milano, Italy; lucelli{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Van Heel and West (Gut 2006;55:1037–46) published a very complete and up to date review on coeliac disease (CD), dealing very clearly with all aspects of CD, from clinical problems to basic science. In the last paragraph they introduce a very “hot topic”, future therapeutic perspectives of CD, involving immunosuppressive drugs, introduction of non-toxic cereals, development of inhibitors of the enzyme tissue transglutaminase, etc. However, the possibility of introducing drug based therapy for CD brings forth some ethical considerations.

A gluten free diet (GFD) is currently the only available …

View Full Text


  • Conflict of interest: None declared.

Linked Articles

  • Recent advances in clinical practice
    D A van Heel J West